Following
Ripple argues SEC stalls case amid refusal to hand over Bitcoin, Ether and XRP documentsCryptos |
6/7/2021 2:41:20 AM GMT
Ripple Labs has recently filed a motion to compel the United States Securities & Exchange Commission to hand over internal documents on the leading cryptocurrencies.
The SEC has repeatedly refused to produce records on Bitcoin, Ether and XRP.
Judge Sarah Netburn reaffirmed and clarified her order on the case just last month.
In the latest development in the legal battle between the United States Securities & Exchange Commission (SEC) and Ripple Labs, the blockchain firm has filed a motion to compel the government agency to turn over internal documents related to cryptocurrencies, including Bitcoin, Ethereum and XRP.
관심 끌던 전기차 스타트업, 찬밥 신세… 스팩 거품 꺼지나 kmib.co.kr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kmib.co.kr Daily Mail and Mail on Sunday newspapers.
Largo Resources Ltd. reports that it has obtained a receipt for a final short form base shelf prospectus from the securities regulatory authorities in each of the provinces and territories of Canada. A corresponding registration statement on Form F-10 has been filed with the United States Securities and Exchange Commission under the CanadaU.S. Multijurisdictional Disclosure System . The Company filed the Shelf .
Helius Medical Technologies, Inc. Appoints Frederick Fantazzia as Vice President of Sales & Marketing, North America Helius Medical Technologies, Inc. Newtown, Pennsylvania, UNITED STATES
NEWTOWN, Pa., June 02, 2021 (GLOBE NEWSWIRE) Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the appointment of Frederick Fantazzia to the position of Vice President of Sales & Marketing, North America, effective June 1, 2021.
“Fred is a dynamic leader with 16 years of sales and marketing experience in the field of neuromodulation, and a specific focus on developing the market for new neuromodulation technologies by building and leading high-quality sales team to raise awareness and facilitate commercial adoption,” said Dane Andreeff, Interim President and Chief Executive Officer of Helius. “We are pleased to welcome him to our leadership team an